Cholesterol Animations, Lipoprotein Animations, Statins Animations

Abbott's SIMCOR(R) (Niacin Extended-Release / Simvastatin) Receives FDA Approval For New Dosage Strengths
Abbott received U.S. Food and Drug Administration (FDA) approval for two new dosage strengths of SIMCOR®, a cholesterol medication. The new SIMCOR dosage strengths combine 40 mg of simvastatin - the most commonly prescribed dose of simvastatin - with either 500 mg or 1,000 mg of niacin extended-release...

Abbott's SIMCOR ® ( Niacin Extended-release / Simvastatin ) Receives FDA Approval For New Dosage Strengths
Abbott (NYSE: ABT) received U.S. Food and Drug Administration (FDA) approval for two new dosage strengths of SIMCOR®, a cholesterol medication. The new SIMCOR dosage strengths combine 40 mg of simvastatin the most commonly prescribed dose of simvastatin with either 500 mg or 1,000 mg of niacin extended-release...

Preventing Heart Problems While Keeping A Cool Head
Max Planck researchers explain the cause of the flushing effect arising from cholesterol treatment with nicotinic acid. Cholesterol influences the health of our hearts and blood vessels. Conventional treatment attempts to reduce the level of "bad" cholesterol, LDL cholesterol, in the blood plasma...

No Firm Conclusions About HDL Cholesterol Can Be Drawn From JUPITER Sub-analysis
No firm conclusions about HDL cholesterol can be drawn from JUPITER sub-analysis Sophia Antipolis, 23 July 2010: The European Society of Cardiology (ESC) is concerned that interpretations of a paper about cholesterol, published in the Lancet (1), could act to deter ongoing research efforts into developing new therapeutic strategies to increase high density lipoprotein (HDL) cholesterol...

Good Cholesterol Seems Less Important Once Statins Have Lowered Bad Cholesterol
Results of an international trial suggest that once statins have lowered LDL or "bad" cholesterol, the level of HDL or "good" cholesterol is less important in terms of predicting cardiovascular risk than it is during pre-treatment assessment...

New Links Between Cholesterol And Depression In The Elderly
Most people know that high cholesterol levels place them at increased risk for heart disease and stroke. Prior research has shown that particular types of strokes contribute to one's risk for depression, and that abnormal blood lipid levels can increase the risk of depression in the elderly...

News From The American Academy Of Family Physicians, July/August 2010
American Academy of Family Physicians - Coca-Cola Alliance, Conflict of Interest or Ethical Relationship? In an essay addressing the recent controversy over the American Academy of Family Physicians accepting a large corporate donation from The Coca-Cola Company to fund patient education materials on obesity prevention, family physician and AAFP member Howard Brody, M.D., Ph.D...

Recordati : Positive Conclusion To The Decentralized Procedure For The Approval In Europe Of Pitavastatin (Livazo®)
Recordati announces the positive outcome of the Decentralized Procedure for the approval of pitavastatin (Livazo®, Alipza® and other brands) in Europe following the communication from the Reference Member State (MHRA, Medicines and Healthcare products Regulatory Agency, UK) and the agreement of all the Concerned Member States which was received by Kowa...

Pfizer Announces European Union Approval Of A New Form Of Lipitor (atorvastatin) For Use In Children
Pfizer Inc...

Leading Cholesterol Tests May Not Be Accurate In All Situations, Research Team Concludes
The National Cholesterol Education Program maintains guidelines to assess the accuracy of methods for measuring cholesterol levels in patients. A recent study published in the journal Clinical Chemistry found that seven leading commercial methods produce results of mixed accuracy when compared to well-established techniques...

Study Supports Universal Cholesterol Screening Of Children
Relying on family history alone to decide which children should be screened for high cholesterol could miss many children who need treatment, according to the study, "Universal Versus Targeted Blood Cholesterol Screening Among Youth: The CARDIAC Project," published in the August print issue of Pediatrics (published online July 12)...

New Study Reveals More Than Half Of Statin-Treated CVD Patients Are Not Reaching Optimal LDL-C Targets
The analysis of the UK patient population from the DYSlipidaemia International Study (DYSIS UK), sponsored by MSD, found that 77.0% of the 383 statin-treated patients at high-risk from cardiovascular disease (CVD) who were studied achieved the JBS 2 guidelines' minimum standard of care*.(1) However, the study also found that 54...

Another Way Out For Cholesterol
Many of us are simply overloaded with cholesterol, and now a report in the July issue of Cell Metabolism brings what might be good news: There is more than one way to get rid of that cholesterol, which can otherwise lead to atherosclerosis and heart disease. "Cholesterol really can't be broken down," said Mark Brown of Wake Forest University School of Medicine...

Better Understanding Of Body's Response To Fasting May Lead To Therapies For Metabolic Disorders
Massachusetts General Hospital (MGH) investigators have found that an enzyme with several important roles in energy metabolism also helps to turn off the body's generation of fats and cholesterol under conditions of fasting...

Biospherics Acquires Global Patent Rights From University Of Kentucky Research Foundation To Develop Tagatose As A Trigylcerides Therapy
Spherix Incorporated (Nasdaq: SPEX), an innovator in biotechnology for therapy in diabetes, metabolic syndrome, and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, announced that its wholly-owned subsidiary, Biospherics Incorporated, has signed a license agreement with the University...